Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease.
Blandini
F
F
Laboratory of Functional Neurochemistry, Neurological Institute C. Mondino, Via Palestro, 3 27100 Pavia, Italy. fabio.blandini@mondino.it
Fancellu
R
R
Martignoni
E
E
Mangiagalli
A
A
Pacchetti
C
C
Samuele
A
A
Nappi
G
G
D000978:Antiparkinson Agents / Q000097:blood* / Q000378:metabolism / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives / Q000097:blood; D004298:Dopamine / Q000097:blood; D005260:Female; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D007980:Levodopa / Q000097:blood* / Q000378:metabolism / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000097:blood* / Q000188:drug therapy / Q000378:metabolism; D014443:Tyrosine / Q000031:analogs & derivatives
D000978:Antiparkinson Agents; D006710:Homocysteine; D014443:Tyrosine; D007980:Levodopa; D004295:Dihydroxyphenylalanine; C008404:3-methoxytyrosine; D004298:Dopamine